Is Rituxan and MabThera the same?
In Europe, MabThera has recently been approved in paediatric indications in GPA/MPA patients for induction of remission and previously untreated B-NHL, in combination with chemotherapy. In the United States, Japan and Canada, MabThera is marketed as Rituxan.
What is the difference between Rituxan and rituximab?
Rituxan is the trade name for rituximab. In some cases, health care professionals may use the trade name rituxan when referring to the generic drug name rituximab. Drug type: Rituximab is a monoclonal antibody. (For more detail, see “How this drug works” section below).
What type of immunotherapy is Rituxan?
Rituximab (Rituxan) is the monoclonal antibody that doctors most often use to treat lymphoma. This drug targets the CD20 antigen, which many types of lymphoma make too much of. CD20 is found on a type of white blood cell called a B cell.
Is MabThera chemotherapy?
MabThera may be given with or without chemotherapy. When given in combination with chemotherapy, the standard treatment with MabThera consists of 1 infusion on day 1 of each chemotherapy cycle. Depending on the circumstances of your disease or response to the drug your doctor may decide to change your treatment.
Who makes MabThera?
Rituxan, developed by Roche’s Genentech, has the distinction of being the first monoclonal antibody treatment for cancer. And even after 15 years on the market, it continues to see its sales grow, up 6% for Roche in 2013.
Is Rituxan chemotherapy or immunotherapy?
RITUXAN is not chemotherapy RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy. They work in different ways to find and attack the cells where cancer starts. RITUXAN targets and attaches to the CD20 protein found on the surface of blood cells with cancer and some healthy blood cells.
What steroid is used with Rituxan?
Rituxan is approved to treat a condition known as granulomatosis with polyangiitis in adults as well as children ages 2 years and older. The GPA must be moderate to severe. For this purpose, Rituxan is used with drugs called glucocorticoids, such as prednisone.
Is rituximab immunotherapy or chemotherapy?
Rituximab was approved by the US Food and Drug Administration for use in DLBCL nearly 20 years ago. It was the first immunotherapy approved for specific use in cancer, and it quickly demonstrated a dramatic improvement in outcomes in patients with DLBCL when combined with chemotherapeutic agents.
How many times can rituximab be given?
Administer RITUXAN as a single-agent every 8 weeks for 12 doses. Following completion of 6-8 cycles of CVP chemotherapy, administer once weekly for 4 doses at 6-month intervals to a maximum of 16 doses.
What do you need to know about rituximab (MabThera)?
Rituximab (Mabthera, Truxima) 1 How rituximab works. Rituximab is a monoclonal antibody. 2 How you have rituximab. You might have rituximab on its own or with other cancer drugs… 3 When you have rituximab. For NHL, you may have rituximab in combination with other cancer drugs… 4 Tests. You have blood tests before and during your treatment.
What is the difference between rituximab and a biosimilar?
You might have the original rituximab drug called Mabthera, or a biosimilar such as Truxima or Rixathon. A biosimilar is a very similar copy of the original drug, but it is not exactly the same. Biosimilars undergo strict testing to check they work just as well as the original drug. Rituximab is a monoclonal antibody.
What is the mechanism of action of rituximab?
Rituximab is a monoclonal antibody. It targets a protein called CD20 on the surface of the leukaemia and lymphoma cells.
What is Mabthera used for in rheumatoid arthritis?
Rituximab (Rituxan and MabThera) Rituximab (Rituxan and MabThera) is a drug used to treat rheumatoid arthritis that has not improved with other types of medications, as well as certain forms of vasculitis.